Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels

被引:76
作者
Lam, Francis F. Y. [1 ]
Yeung, John H. K. [1 ]
Kwan, Yiu W. [1 ]
Chan, Kam M. [1 ]
Or, Penelope M. Y. [1 ]
机构
[1] Chinese Univ Hong Kong, Dept Pharmacol, Fac Med, Shatin, Hong Kong, Peoples R China
关键词
salvianolic acid B; danshen; Salvia miltiorrhiza; calcium channel; coronary artery;
D O I
10.1016/j.ejphar.2006.09.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we have investigated the mechanism of action through which salvianolic acid, a constituent of the medicinal herb danshen (Salvia miltiorrhiza), causes relaxation of isolated coronary artery rings precontracted with 1 mu M 5-hydroxyttyptamine (5-HT). The vasorelaxant effects of salvianolic acid B were also compared with the aqueous extract of danshen. Extraction of the water-soluble fraction from danshen provided a yield of 17.5%. The amount of salvianolic acid B determined in this aqueous extract was 3.9%, and the extract was 6.3 times less potent than salvianolic acid B in relaxing 5-HT-precontracted coronary artery rings; IC50 values were 930.3 +/- 133.5 mu g/ml and 147.9 +/- 17.4 mu g/ml, respectively. Removal of the endothelium did not significantly affect their vasodilator potencies; IC50 values were 842.1 +/- 123.8 mu g/ml and 160.3 25.9 mu g/ml. On the other hand, a potassium channel inhibitor tetraethylammonium (TEA, 10 mM) shifted their concentration-response curves by 1.7 and 2.9 folds. The possible involvement of Ca2+ channels was investigated in artery rings incubated with Ca2+-free buffer and primed with 1 mu M 5-HT or 60 mM KCl for 5 min prior to adding CaCl, to elicit contraction. In 5-HT-primed preparations, 2 mg/ml danshen aqueous extract and 0.72 mg/ml salvianolic acid B abolished the CaCl2-induced vasoconstriction, whereas, in KCl-primed preparations, 10 mg/ml danshen aqueous extract and 1.44 mg/ml salvianolic acid B produced 90% inhibition. These findings suggest the vasorelaxant effects of danshen aqueous extract and salvianolic acid B were produced by inhibition of Ca2+ influx in the vascular smooth muscle cells. The opening of K+ channels had a minor contribution to their effects, but endothelium-dependent mechanisms were not involved. The high vasodilator potency and the quantity of salvianolic acid B contained in danshen aqueous extract suggest it is an important vasodilator constituent in this medicinal herb.(c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 32 条
  • [1] Salvia miltiorrhiza attenuates the changes in contraction and intracellular calcium induced by anoxia and reoxygenation in rat cardiomyocytes
    Cao, CM
    Xia, QA
    Zhang, X
    Xu, WH
    Jiang, HD
    Chen, JZ
    [J]. LIFE SCIENCES, 2003, 72 (22) : 2451 - 2463
  • [2] Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction
    Chan, K
    Chui, SH
    Wong, DYL
    Ha, WY
    Chan, CL
    Wong, RNS
    [J]. LIFE SCIENCES, 2004, 75 (26) : 3157 - 3171
  • [3] Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis
    Chen, JH
    Wang, FM
    Lee, FSC
    Wang, XR
    Xie, MY
    [J]. TALANTA, 2006, 69 (01) : 172 - 179
  • [4] Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463
  • [5] Cheng Y Y, 1990, Zhong Xi Yi Jie He Za Zhi, V10, P609
  • [6] DEMONSTRATION OF THE MYOCARDIAL SALVAGE EFFECT OF LITHOSPERMIC ACID-B ISOLATED FROM THE AQUEOUS EXTRACT OF SALVIA-MILTIORRHIZA
    FUNG, KP
    ZENG, LH
    WU, J
    WONG, HNC
    LEE, CM
    HON, PM
    CHANG, HM
    WU, TW
    [J]. LIFE SCIENCES, 1993, 52 (22) : PL239 - PL244
  • [7] GODFRAIND T, 1986, PHARMACOL REV, V38, P321
  • [8] Huang Y, 1996, Chin J Physiol, V39, P1
  • [9] Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats
    Ji, XY
    Tan, BKH
    Zhu, YC
    Linz, W
    Zhu, YZ
    [J]. LIFE SCIENCES, 2003, 73 (11) : 1413 - 1426
  • [10] Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089